Sarcopenic Obesity in Neurodisabilities

  • End date
    May 21, 2022
  • participants needed
  • sponsor
    Dionyssiotis, Yannis, M.D.
Updated on 21 July 2021
spinal cord
traumatic brain injury
spinal cord disorder
cerebrovascular diseases
disease or disorder
multiple sclerosis


To describe the frequency and thresholds for sarcopenic obesity in neurodisabled persons and the fat and lean mass distribution based on various neurodisabilities

Condition Multiple Sclerosis, Spinal Cord Injury, Myelopathy, Brain Injury, Trauma, Cerebrovascular accident, Sarcopenic Obesity, Radiologically Isolated Syndrome, Dermatite Atopique modérée ou grave, Spinal Cord Injuries, Stroke, Traumatic Brain Injury, Wounds, Spinal Cord Disorders, Brain Injuries, Traumatic, multiple sclerosis (ms), traumatic brain injury (tbi), cerebrovascular accidents, strokes, cerebral
Treatment whole body DXA
Clinical Study IdentifierNCT03863379
SponsorDionyssiotis, Yannis, M.D.
Last Modified on21 July 2021


Yes No Not Sure

Inclusion Criteria

Persons with
stroke / cerebrovascular disease
traumatic brain injury
multiple sclerosis
spinal cord injuries (including spinal cord lesions i.e. myelopathies etc.)

Exclusion Criteria

Persons with
heterotopic ossifications
chronic administration of drugs, which promote fat increase
chronic administration of drugs, which promote bone or muscle loss
co-existing other diseases such as: endocrinopathies, muscular dystrophies, non-alcoholic fatty liver disease
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note